CliffBio
small molecule

DULOXETINE HYDROCHLORIDE

DULOXETINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameDULOXETINE HYDROCHLORIDE
Active ingredientDULOXETINE HYDROCHLORIDE
StrengthEQ 30MG BASE
Dosage formCAPSULE, DELAYED REL PELLETS
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2013
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DULOXETINE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio